To contribute to the development of a rubella vaccination strategy, we conducted a study to determine age-specific susceptibility among women aged 15-39 years by testing for rubella-specific IgG antibodies. Of 964 women, 13% were found to be susceptible to rubella. Significantly higher susceptibility among women 125 years old was observed. Susceptibility data are important but are not sufficient to develop a vaccination strategy. After considering all available information, we suggested vaccination of women aged !35 years and selective vaccination of older women who were planning pregnancy.
To contribute to the development of a rubella vaccination strategy, we conducted a study to determine age-specific susceptibility among women aged 15-39 years by testing for rubella-specific IgG antibodies. Of 964 women, 13% were found to be susceptible to rubella. Significantly higher susceptibility among women 125 years old was observed. Susceptibility data are important but are not sufficient to develop a vaccination strategy. After considering all available information, we suggested vaccination of women aged !35 years and selective vaccination of older women who were planning pregnancy.
Rubella usually is a mild febrile rash illness in children and adults. However, serious consequences, such as fetal death, miscarriages, stillbirths, and congenital rubella syndrome (CRS) may occur as a result of intrauterine infection, particularly during the first trimester of pregnancy. According to recent estimates, 1100,000 cases of CRS occur annually in developing countries; thus, prevention of congenital infections is the primary goal of any rubella vaccination program [1] .
Worldwide experience has shown that the optimum ap-proach to preventing congenital rubella infection entails immunizing both children and women of childbearing age [2] [3] [4] . In 1999, Kyrgyzstan adopted a plan for measles elimination and CRS prevention. After considering the cost-benefit analysis of a combined measles-rubella (MR) vaccination program, the Kyrgyz Ministry of Health (MOH) planned to introduce the MR vaccine in November 2001, during a mass campaign for measles vaccination that targeted all persons aged 7-25 years. This age range was determined on the basis of age-specific measles susceptibility. The MOH planned to introduce the measles-mumps-rubella vaccine into the routine schedule of childhood vaccinations in January 2002, with doses administered at 12 months of age and 6-7 years of age, to be followed in November 2002 by rubella vaccination of women aged 125 years. A 40-fold increase in the incidence of rubella infection among persons aged 15-35 years was observed during the 2001 rubella outbreak, which raised further concerns about the potential risk of CRS in Kyrgyzstan [5] . However, no CRS incidence data or rubella susceptibility data were available to determine the appropriate upper age limit for the vaccination of women. To assist the Kyrgyz MOH in developing a vaccination strategy, a susceptibility study was conducted to determine both overall and age-specific susceptibility to rubella among women of childbearing age, prior to the introduction of the rubella vaccine.
Methods. From September to November 2001, prior to implementation of the MR vaccination campaign, we conducted a cross-sectional study in 3 sparsely populated regions that, according to surveillance data, had not been affected by the 2001 rubella outbreak: Talas, Narin, and Issyk-Kul. A convenience sample of women attending obstetric/gynecology clinics for routine serological testing was enrolled. After informed consent was obtained, women aged 15-39 years were asked to provide an additional blood sample for testing for rubellaspecific IgG serum antibodies. Women who refused to provide a blood sample were not enrolled in the study.
Five-year age strata (15-19, 20-24, 25-29, 30-34, and 35-39 years) were used to describe susceptibility levels. Assuming an upper limit of susceptibility of 30% and allowing for a 95% CI of 23%-37%, each stratum needed 165 participants (as determined with EpiInfo Statcalc; version 6.04b, Centers for Disease Control and Prevention [CDC]), for a total of 825 participants, to detect the differences in susceptibility between age groups. The number of participants from each region was adjusted to the age-specific birth rate there, yielding enrollment targets of 701 women for Issyk-Kul, 56 for Talas, and 68 for Narin. Data were analyzed using EpiInfo, version 6.04b. The Pearson x 2 test was used to examine the association between susceptibility and age. National statistics on birth distribution by maternal age were reviewed to determine the age-specific birth pattern in Kyrgyzstan.
All tests were performed at the National Virology Laboratory in Kyrgyzstan. The Dade Behring enzyme immunoassay was used for detection of rubella-specific IgG antibodies, according to the manufacturer's specifications. Laboratory procedures were validated with control serum samples (1 IgG-negative and 1 IgG-positive) provided by the CDC (Atlanta, GA) and originally tested using Wampole Rubella IgG kits. The limit of detection of the test is 4 IU/mL. Individuals having an IgG titer of 18 IU/mL (equivalent optical density, 10.2) were defined as being seropositive. Titers of 4-8 IU/mL were classified as equivocal. In the analysis, women with equivocal or negative test results were considered susceptible, which yielded a maximum estimate of rubella susceptibility for the purpose of developing a vaccination strategy.
Results. We obtained blood samples from 964 women. The targeted number of women enrolled in each age group was reached in all groups except women aged 15-19 years, for whom 77% of the target was attained. The number of women enrolled at each site was 810 in Issyk-Kul, 79 in Narin, and 75 in Talas.
Of the 964 women, 129 (13.4 %) had negative or equivocal test results (table 1). The differences in susceptibility among age groups were statistically significant (x 2 , 10.6; ; P p .03 ). A statistically significant difference ( ) was df p 4 P p .003 found between the youngest groups of women (15-24 years old) and the oldest (25-39 years old). Even when we adjusted the P value for multiple comparisons, women aged 20-24 years had a significantly different susceptibility level, compared with both women aged 25-29 ( ) and women aged 30-34 P p .04 years ( ). P p .04 A review of national statistics on birth distribution by maternal age for the year 2000 revealed that 11% of all births in Kyrgyzstan occurred among women aged 15-19 years, 34% among those aged 20-24 years, 28% among those aged 25-29 years, 17% among those aged 30-35 years, and 9% among those aged 35-39 years. Applying this distribution of births to the proportion of women in each age group defined by our study as being susceptible, we estimated susceptible births by the age of the mother. Sixty-eight percent of births to susceptible mothers occurred among women aged 125 years (table 2) .
Discussion. Our findings showed a higher proportion of women who were susceptible to rubella among those aged 25-39 years than among women aged !25 years. The likely explanation is lack of exposure to rubella virus among women 125 years old. Waning immunity has not been an issue of clinical and/or epidemiological significance for naturally acquired rubella, but declines in antibody titer have been documented for rubella [6] , particularly among vaccinated persons. As shown in table 1, more women aged 125 years have equivocal results, compared with women !25 years of age.
We found that up to 13% of women of childbearing age were susceptible to rubella. Although a high level of susceptibility in a population (120%) is likely to indicate a high risk of CRS, a low level of susceptibility (!10%) cannot be taken to mean there is no risk of CRS [7] . Moreover, in different geographical areas, similar levels of susceptibility do not necessarily predict the same risk of CRS, because of the variation in the force of infection, population density, migration and birth patterns, and other factors [8, 9] . In addition, comparison of susceptibility levels is difficult because of the different designs and timing of studies in relation to previous outbreaks, the variability of testing and titer cutoff points used to define susceptibility, and the presence or absence of a previous vaccination program. Therefore, the ability to draw conclusions from susceptibility data alone is limited [4] . Also, our results may have limited generalizability for all women of childbearing age in Kyrgyzstan, because we used a convenience-sample methodology. Considering that high population density and/or recent rubella outbreaks are associated with greater rubella immunity, the builtin bias of choosing rural, sparsely populated, and areas where rubella is not epidemic likely provides a maximum estimate of the general susceptibility, as does assuming that women with equivocal results are susceptible.
In addition to susceptibility data, we used all available evidence, such as distribution of birth by maternal age, the epidemiology of rubella, and the impact of previous vaccination strategies, to develop an optimal rubella vaccination strategy [3, [10] [11] [12] .
In Kyrgyzstan, the risk of CRS among susceptible women aged 125 years remains, because 54% of births occur among women aged 25-39 years who were not targeted by the 2001 MR vaccination campaign. The high vaccination coverage (98% of the target population, according to MOH data) attained during this campaign likely reduced rubella virus transmission in the population substantially. Introduction of the rubella vaccine into the routine immunization schedule will curtail future transmission, but it will take at least 4 years to vaccinate all children aged !7 years, during which time circulation of the virus may continue in this age group. Meanwhile, susceptible women aged 125 years remain at risk-although at decreased risk-for rubella exposure. In addition, if childhood immunization coverage does not remain high, transmission patterns may shift toward adults, including women of childbearing age; this may result in cases of CRS [1, 4, 12, 13] .
To avoid the potential harm of such a shift, it is essential to assure high levels of rubella immunity among all women of childbearing age when childhood immunizations are initiated. The significantly higher susceptibility rate and the higher proportion of births to susceptible mothers among women aged 125 years, compared with younger women, supports the need to target this group for vaccination. Therefore, rubella vaccination of all women aged 26-35 years was suggested in Kyrgyzstan, through routine services or mass campaigns. Selective vaccination of women aged 135 years who were planning pregnancy was advised, because only 11% of births occur among women 135 years old, and resources were limited. This 3-tiered rubella vaccination program in Kyrgyzstan is expected to reduce significantly the risk of rubella infection and CRS (table 3) .
Although susceptibility data are important, they are not sufficient to develop a vaccination strategy unless considered in the context of other factors, such as the burden of CRS, distribution of births by maternal age, and the epidemiology of rubella, including the impact of any previous vaccination strategy. Furthermore, to avoid the potential harm caused by inadequate rubella vaccination, the availability of resources to sustain an adequate rubella immunization program over the long term should be assessed before the introduction of rubella vaccination [12] .
